AF
LUCD icon

Allworth Financial’s Lucid Diagnostics LUCD Stock Holding History

Allworth Financial’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2K Buy
2,058
+1,745
+558% +$1.88K ﹤0.01% 4473
2026
Q1 		$360 Buy
313
+242
+341% +$308 ﹤0.01% 4811
2025
Q4 		$78 Sell
71
-126
-64% -$141 ﹤0.01% 4806
2025
Q3 		$199 Buy
197
+87
+79% +$95 ﹤0.01% 4603
2025
Q2 		$127 Hold
110
– – ﹤0.01% 4373
2025
Q1 		$147 Hold
110
– – ﹤0.01% 3915
2024
Q4 		$91 Sell
110
-57
-34% -$50 ﹤0.01% 3848
2024
Q3 		$137 Buy
167
+10
+6% +$8 ﹤0.01% 3641
2024
Q2 		$132 Hold
157
– – ﹤0.01% 3588
2024
Q1 		$128 Buy
+157
New +$204 ﹤0.01% 3495

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Allworth Financial's LUCD Position: Q2 2026 in Review

Allworth Financial increased its Lucid Diagnostics (LUCD) stake by 558% in Q2 2026, buying an estimated $1.88K and bringing the position to 2,058 shares worth $2.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4473.

Allworth Financial first reported a position in LUCD in Q1 2024 and has held it in 10 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Allworth Financial held 2,058 shares of Lucid Diagnostics worth $2.2K as of Q2 2026.
  • Allworth Financial bought 1,745 Lucid Diagnostics shares in Q2 2026, an estimated $1.88K.
  • Lucid Diagnostics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4473 holding.
  • Allworth Financial first reported a position in Lucid Diagnostics in Q1 2024 and has held it in 10 quarters since.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.